NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 121 filers reported holding NURIX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,609,345 | -25.3% | 968,110 | -5.1% | 0.05% | -27.0% |
| Q2 2023 | $10,188,022 | +38.5% | 1,019,822 | +13.3% | 0.07% | +45.1% |
| Q1 2023 | $7,356,810 | -21.2% | 900,088 | +5.8% | 0.05% | -19.0% |
| Q4 2022 | $9,338,876 | -13.2% | 850,575 | +3.0% | 0.06% | -17.1% |
| Q3 2022 | $10,757,000 | +1.2% | 825,575 | -1.6% | 0.08% | -13.6% |
| Q2 2022 | $10,634,000 | -0.8% | 839,375 | +9.7% | 0.09% | +20.5% |
| Q1 2022 | $10,718,000 | -53.4% | 765,106 | -3.7% | 0.07% | -50.3% |
| Q4 2021 | $22,989,000 | +38.3% | 794,103 | +43.1% | 0.15% | +30.1% |
| Q3 2021 | $16,627,000 | +23.5% | 554,996 | +9.4% | 0.11% | +22.8% |
| Q2 2021 | $13,458,000 | – | 507,303 | +3902230.8% | 0.09% | – |
| Q1 2021 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |